actbiotechАктуальная биотехнологияTopical biotechnology2304-4691ВГУИТ10.20914/2304-4691-2020-3-631-632actbiotech-5028Research ArticleСтатьиАНТИБАКТЕРИАЛЬНЫЕ СВОЙСТВА БЕТА-ГЛЮКАНОВАйрапетянО. Н.noemail@neicon.ruИвановаВ. А.noemail@neicon.ruМелединаТ. В.noemail@neicon.ruКульминскаяА. А.noemail@neicon.ruКурчатовский институтRussian FederationСанкт-Петербургский университет технологий, механики и оптикиRussian Federation20202609202003631632Copyright © Айрапетян О.Н., Иванова В.А., Меледина Т.В., Кульминская А.А., 20202020Айрапетян О.Н., Иванова В.А., Меледина Т.В., Кульминская А.А.Айрапетян О.Н., Иванова В.А., Меледина Т.В., Кульминская А.А.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.actbio-vsuet.ru/jour/article/view/5028ReferencesClaire Barton, Kim Vigor, Robert Scott, Paul Jones, Heike Lentfer, Heather J Bax, Debra H Josephs, Sophia N Karagiannis, James F Spicer Beta-glucan contamination of pharmaceutical products: How much should we accept? Cancer Immunol Immunother. 2016 Nov;65(11):1289-1301.Claire Barton, Kim Vigor, Robert Scott, Paul Jones, Heike Lentfer, Heather J Bax, Debra H Josephs, Sophia N Karagiannis, James F Spicer Beta-glucan contamination of pharmaceutical products: How much should we accept? Cancer Immunol Immunother. 2016 Nov;65(11):1289-1301.Vetvicka V, Vannucci L, Sima P, Richter J. Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials. Molecules. 2019;24(7):1251. Published 2019 Mar 30. doi:10.3390/molecules24071251Vetvicka V, Vannucci L, Sima P, Richter J. Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials. Molecules. 2019;24(7):1251. Published 2019 Mar 30. doi:10.3390/molecules24071251OlafsdottirES, Omarsdottir S, PaulsenBS, Wagner H. Immunologically active O6 branched (1→3) -beta-glucanfrom the lichen Thamnolia vermicularis var. subuliformis. Phytomedicine. 2003;10(4):318-324. doi:10.1078/094471103322004811OlafsdottirES, Omarsdottir S, PaulsenBS, Wagner H. Immunologically active O6 branched (1→3) -beta-glucanfrom the lichen Thamnolia vermicularis var. subuliformis. Phytomedicine. 2003;10(4):318-324. doi:10.1078/094471103322004811Ivanova V., Antontceva E., Harbah R., Meledina T.V., Shamtsyan M. Residual brewing yeasts as a source of beta-glucans. E3S Web of Conferences. 2020. Vol. 164. pp. 06027.Ivanova V., Antontceva E., Harbah R., Meledina T.V., Shamtsyan M. Residual brewing yeasts as a source of beta-glucans. E3S Web of Conferences. 2020. Vol. 164. pp. 06027.BiemerJJ. Antimicrobial susceptibility testing by the Kirby-Bauer disc diffusion method. Ann Clin Lab Sci. 1973;3(2):135- 140.BiemerJJ. Antimicrobial susceptibility testing by the Kirby-Bauer disc diffusion method. Ann Clin Lab Sci. 1973;3(2):135- 140.AminRM, Abdel-KaderNS, El-AnsaryAL. Microplate assay for screening the antibacterial activity of Schiff bases derived from substituted benzopyran 4 one. Spectrochim Acta A Mol Biomol Spectrosc. 2012;95:517-525. doi:10.1016/j.saa.2012.04.042AminRM, Abdel-KaderNS, El-AnsaryAL. Microplate assay for screening the antibacterial activity of Schiff bases derived from substituted benzopyran 4 one. Spectrochim Acta A Mol Biomol Spectrosc. 2012;95:517-525. doi:10.1016/j.saa.2012.04.042
The authors declare that there are no conflicts of interest present.